-
EP1313769
European procedure
Extract from the Register of European Patents
EP About this file: EP1313769
| EP1313769 - ANTIBODIES TO HUMAN IL-1 BETA [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 07.10.2011 Database last updated on 02.04.2025 | Most recent event Tooltip | 07.10.2011 | Patent maintained (B2 publication) | published on 09.11.2011 [2011/45] | Applicant(s) | For:BE
CH
CY
DE
DK
ES
FI
FR
GB
GR
IE
IT
LI
LU
MC
NL
PT
SE
TR
Novartis AG Lichtstrasse 35 4056 Basel / CH | For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | [2011/45] |
| Former [2006/29] | For:BE
CH
CY
DE
DK
ES
FI
FR
GB
GR
IE
IT
LI
LU
MC
NL
PT
SE
TR
Novartis AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | |||
| Former [2003/22] | For:BE
CH
CY
DE
DK
ES
FI
FR
GB
GR
IE
IT
LU
MC
NL
PT
SE
TR
Novartis AG Lichtstrasse 35 4056 Basel / CH | ||
| For:AT
Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT | Inventor(s) | 01 /
GRAM, Hermann Am Bischofsacker 20 79576 Weil / DE | 02 /
DI PADOVA, Franco, E. Kluenenfeldstrasse 45 CH-4127 Birsfelden / CH | [2003/22] | Representative(s) | Jaenichen, Hans-Rainer, et al Vossius & Partner Siebertstrasse 4 81675 München / DE | [N/P] |
| Former [2009/47] | Jaenichen, Hans-Rainer, et al VOSSIUS & PARTNER Siebertstr. 4 81675 München / DE | ||
| Former [2003/22] | Gros, Florent, et al Novartis AG 4002 Basel / CH | Application number, filing date | 01976118.8 | 20.08.2001 | [2003/22] | WO2001EP09588 | Priority number, date | GB20000020685 | 22.08.2000 Original published format: GB 0020685 | [2003/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0216436 | Date: | 28.02.2002 | Language: | EN | [2002/09] | Type: | A2 Application without search report | No.: | EP1313769 | Date: | 28.05.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.02.2002 takes the place of the publication of the European patent application. | [2003/22] | Type: | B1 Patent specification | No.: | EP1313769 | Date: | 21.05.2008 | Language: | EN | [2008/21] | Type: | B2 New European patent specification | No.: | EP1313769 | Date: | 09.11.2011 | Language: | EN | [2011/45] | Search report(s) | International search report - published on: | EP | 20.06.2002 | Classification | IPC: | C07K16/24, A61K39/395 | [2011/45] | CPC: |
C07K16/245 (EP,US);
C07K16/00 (KR);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/04 (EP);
A61P19/10 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P39/02 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
A61K2039/505 (EP,US);
|
| Former IPC [2003/22] | C07K16/00 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/22] | Extension states | RO | 24.03.2003 | SI | 24.03.2003 | Title | German: | ANTIKÖRPER GEGEN IL-1 BETA | [2003/22] | English: | ANTIBODIES TO HUMAN IL-1 BETA | [2003/22] | French: | ANTICORPS DE LA IL-1 BETA HUMAINE | [2003/22] | Entry into regional phase | 24.03.2003 | National basic fee paid | 24.03.2003 | Designation fee(s) paid | 24.03.2003 | Examination fee paid | Examination procedure | 09.03.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 24.03.2003 | Examination requested [2003/22] | 03.03.2006 | Despatch of a communication from the examining division (Time limit: M04) | 29.06.2006 | Reply to a communication from the examining division | 29.10.2007 | Cancellation of oral proceeding that was planned for 09.11.2007 | 29.10.2007 | Minutes of oral proceedings despatched | 09.11.2007 | Date of oral proceedings (cancelled) | 23.11.2007 | Communication of intention to grant the patent | 06.03.2008 | Fee for grant paid | 06.03.2008 | Fee for publishing/printing paid | Opposition(s) | Opponent(s) | 01
23.02.2009
ADMISSIBLE Graf von Stosch, Andreas Philip Gehrig Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München / DE Opponent's representative Graf von Stosch, Andreas Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstraße 22 80538 München / DE | [N/P] |
| Former [2009/14] | |||
| Opponent(s) | 01
23.02.2009
ADMISSIBLE Graf von Stosch, Andreas Bosch Graf von Stosch Jehle Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München / DE Opponent's representative Graf von Stosch, Andreas Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München / DE | 01.04.2009 | Invitation to proprietor to file observations on the notice of opposition | 09.10.2009 | Reply of patent proprietor to notice(s) of opposition | 18.01.2011 | Legal effect of interlocutory decision in opposition | 18.01.2011 | Date of oral proceedings | 02.03.2011 | Despatch of interlocutory decision in opposition | 02.03.2011 | Despatch of minutes of oral proceedings | 17.06.2011 | Despatch of communication that the patent will be maintained as amended | 27.09.2011 | Fee for printing new specification paid | Fees paid | Renewal fee | 01.09.2003 | Renewal fee patent year 03 | 31.08.2004 | Renewal fee patent year 04 | 31.08.2005 | Renewal fee patent year 05 | 31.08.2006 | Renewal fee patent year 06 | 31.08.2007 | Renewal fee patent year 07 | 31.03.2008 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US534858 (OTSUKA PHARMACEUTICAL) [A] 1-12 * column 5 - column 6 *; | [A]EP0267611 (OTSUKA PHARMA CO LTD [JP]) [A] 1-12* abstract *; | [X]US4935343 (ALLISON ANTHONY C [US], et al) [X] 1-7,11,12 * table 1 *; | [DX]WO9501997 (SMITHKLINE BEECHAM CORP [US], et al) [DX] 1-3,5-9,11,12 * example 5; table 4 *; | [X] - JACKSON J R ET AL, "IN VITRO ANTIBODY MUTARATION IMPROVEMENT OF A HIGH AFFINITY, NEUTRALIZING ANTIBODY AGAINST IL-1BETA", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, (19950401), vol. 154, no. 7, ISSN 0022-1767, pages 3310 - 3319, XP000941315 [X] 1-3,5-9,11,12 * table II * | Examination | - WARD ET AL, NATURE, (1989), vol. 12, no. 341, pages 484 - 485 | - REITER ET AL, J MOL BIOL, (1999), vol. 290, pages 685 - 698 | - BORREBAECK ET AL, BIOTECHNOLOGY, NATURE, (1992), vol. 10, no. 6, pages 697 - 698 |